Adjunctive glucocorticoid therapy in patients with septic shock.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Whether hydrocortisone reduces mortality among patients with septic shock is unclear. METHODS: We randomly assigned patients with septic shock who were undergoing mechanical ventilation to receive hydrocortisone (at a dose of 200 mg per day) or placebo for 7 days or until death or discharge from the intensive care unit (ICU), whichever came first. The primary outcome was death from any cause at 90 days. RESULTS: From March 2013 through April 2017, a total of 3800 patients underwent randomization. Status with respect to the primary outcome was ascertained in 3658 patients (1832 of whom had been assigned to the hydrocortisone group and 1826 to the placebo group). At 90 days, 511 patients (27.9%) in the hydrocortisone group and 526 (28.8%) in the placebo group had died (odds ratio, 0.95; 95% confidence interval [CI], 0.82 to 1.10; P=0.50). The effect of the trial regimen was similar in six prespecified subgroups. Patients who had been assigned to receive hydrocortisone had faster resolution of shock than those assigned to the placebo group (median duration, 3 days [interquartile range, 2 to 5] vs. 4 days [interquartile range, 2 to 9]; hazard ratio, 1.32; 95% CI, 1.23 to 1.41; P<0.001). Patients in the hydrocortisone group had a shorter duration of the initial episode of mechanical ventilation than those in the placebo group (median, 6 days [interquartile range, 3 to 18] vs. 7 days [interquartile range, 3 to 24]; hazard ratio, 1.13; 95% CI, 1.05 to 1.22; P<0.001), but taking into account episodes of recurrence of ventilation, there were no significant differences in the number of days alive and free from mechanical ventilation. Fewer patients in the hydrocortisone group than in the placebo group received a blood transfusion (37.0% vs. 41.7%; odds ratio, 0.82; 95% CI, 0.72 to 0.94; P=0.004). There were no significant between-group differences with respect to mortality at 28 days, the rate of recurrence of shock, the number of days alive and out of the ICU, the number of days alive and out of the hospital, the recurrence of mechanical ventilation, the rate of renal-replacement therapy, and the incidence of new-onset bacteremia or fungemia. CONCLUSIONS: Among patients with septic shock undergoing mechanical ventilation, a continuous infusion of hydrocortisone did not result in lower 90-day mortality than placebo. (Funded by the National Health and Medical Research Council of Australia and others; ADRENAL ClinicalTrials.gov number, NCT01448109 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The three trials [354, 478, 479] also used different inclusion criteria: in ADRENAL [479] eligible patients were those on any dose of vasopressor or inotrope for ≥ 4 h to maintain a MAP > 60 mmHg, and present at the time of randomisation.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationA Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationFleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Cited by
Items 401–500 of 1,000
Garcia, J. B., Xian, J. Z., Pedroza, C., Salahuddin, M., Mak, G., Keene, A., Cherian, S. V., Young, A., Vijhani, P., & Doshi, P. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00657-3 · Cited by 14
Corticosteroids in critically ill patients: A narrative review
Haan, B. J., Blackmon, S. N., Cobb, A., Cohen, H. E., DeVier, M., Perez, M. M., & Winslow, S. F. (2024) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2944 · Cited by 17
“86,87 The mechanism of action for corticosteroids in septic shock includes mitigation of relative adrenal insufficiency as well as sodium retention and reduction of capillary leakage.”
Eligibility Criteria of Randomized Clinical Trials in Critical Care Medicine
Heirali, A., Heybati, K., Sereeyotin, J., Khan, F. A., Yarnell, C. J., Krewulak, K. D., Murthy, S., Burns, K. E. A., Fowler, R., Fiest, K. M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.54944 · Cited by 15
Significances of miRNAs for predicting sepsis mortality: a meta-analysis
Jin, Y., Zhang, Y., Li, Y., & Zheng, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1472124 · Cited by 12
Meersseman, P., Hernández‐Tejero, M., Diaz, J. M., Wauters, J., Hermans, G., Aziz, F., Ceunen, H., Prado, V., Langouche, L., Arteaga, M., et al. (2025) · Liver International · doi:10.1111/liv.70257 · Cited by 14
Martino, N., Sanders, E. K., Ramos, R. B., Portela, I. D. J., Awadalla, F., Lu, S., Chuy, D. S., Poddar, N., Zuo, M. X. G., Balasubramanian, U., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci189570 · Cited by 12
“Cytokine blockade or steroid treatments dampen the initial inflammatory response but also prevent the immune system from fighting and clearing the primary infection (47), which could explain early failures in clinical trials (48–51).”
Corticosteroids for Septic Shock: Another Chapter in the Saga
Yerke, J. R., Strnad, K., & Bauer, S. R. (2019) · Hospital Pharmacy · doi:10.1177/0018578719829416 · Cited by 13
“The CORTICUS and ADRENAL trials included patients in shock, without specific requirements relating to fluid resuscitation or vasopressors.(14,15) This led to a more severely ill population in the Annane et al.”
BackgroundMethodMenich, B. E., Miano, T. A., Patel, G. P., & Hammond, D. A. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019843664 · Cited by 16
Bagate, F., Bedet, A., Tomberli, F., Boissier, F., Razazi, K., de Prost, N., Carteaux, G., & Dessap, A. M. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00852-2 · Cited by 13
“Moreover, in recent randomized controlled trials assessing the benefit of corticosteroid therapy in septic shock, time to weaning from MV was shorter in the intervention group than the placebo group [26, 27].”
BackgroundSon, J.-Y., Shin, S., & Choi, Y. J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060544 · Cited by 18
“, (2018) [25] Hydrocortisone (N = 1853) Placebo (N = 1860) Sepsis adult patients (>18 years) 200 mg/day 200 ≤7 Mortality Resolution of shock Reversal of shock LOS in ICU LOS in hospital Mechanical ventilation-free time Secondary infection Gastrointestinal bleeding”
BackgroundGlucocorticoid resistance and hyperlactatemia: A tag team to worsen sepsis
Aziz, M., & Wang, P. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.007 · Cited by 12
Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
Shapiro, L., Scherger, S. J., Franco‐Paredes, C., Gharamti, A. A., Fraulino, D., & Henao‐Martínez, A. F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910516 · Cited by 14
Not all Shock States Are Created Equal
Khorsand, S., Helou, M. F., Satyapriya, V., Kopanczyk, R., & Khanna, A. K. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2022.11.002 · Cited by 17
Steroids and Survival in Critically Ill Adult Patients: A Meta-analysis of 135 Randomized Trials
Martino, E. A., Redaelli, M. B., Sardo, S., Lembo, R., Giordano, V. F., Winterton, D., Ruggeri, L., Hajjar, L. A., Zangrillo, A., & Landoni, G. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.04.017 · Cited by 12
Lin, L., Gu, H.-Y., Luo, J., Wang, L., Zhang, C., Niu, Y., & Zuo, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01101 · Cited by 14
Lall, R., Mistry, D., Skilton, E., Boota, N., Regan, S. E., Bion, J., Gates, S., Gordon, A. C., Lord, J. M., McAuley, D. F., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043194 · Cited by 12
50 Years of Sepsis Investigation/Enlightenment Among Adults—The Long and Winding Road
Dellinger, R. P., Levy, M. M., Schorr, C., & Townsend, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005203 · Cited by 12
Prediction of prognosis in sepsis patients by the SOFA score combined with miR-150
Yang, J., Liao, Y., Yong-hong, D., Hu, L., & Cai, Y. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/142536 · Cited by 15
Review article: Sepsis in the emergency department – Part 3: Treatment
Williams, J. M., Keijzers, G., Macdonald, S. P. J., Shetty, A., & Fraser, J. F. (2018) · Emergency Medicine Australasia · doi:10.1111/1742-6723.12951 · Cited by 13
“Glucocorticoids for patients with septic shock (ADRENAL) – Venkatesh et al.(38)”
BackgroundHydrocortisone in septic shock: all the questions answered?
Briegel, J., Huge, V., & Möhnle, P. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.120 · Cited by 13
“Recently, two large-scale RCT on hydrocortisone in patients with septic shock were published (13,14).”
BackgroundZhang, X., Huang, K., Wu, Z., Ding, R., Han, J., Zhang, Y., Lu, Y., Lu, Y., & Si, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108971 · Cited by 14
Corticosteroids in sepsis and community-acquired pneumonia
Guzzardella, A., Motos, A., Vallverdú, J., & Torres, A. (2023) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-023-01093-w · Cited by 11
Xu, H., Wang, L., Zhu, X., Zhang, H., Chen, H., & Zhang, H. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.03.013 · Cited by 13
“5,6 However, as a double-edged sword, it has also been associated with a dramatic increase in the number of patients with glucocorticoid-induced ONFH (GC-ONFH), which has previously been reported to account for approximately 10 – 30% of cases of all atraumatic osteonecrosis cases in clinical…”
BackgroundManagement of vasoplegic shock
Mistry, R. N., & Winearls, J. (2024) · BJA Education · doi:10.1016/j.bjae.2024.10.004 · Cited by 13
Wang, X., Wei, C., He, D., Huang, D., Zhao, Y., Ran, L., Wang, X., Yu, H., Liang, Z., & Gong, L. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11027-w · Cited by 15
Fujii, T., Udy, A. A., & Venkatesh, B. (2019) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00521-5 · Cited by 11
Self-citationManagement of patients with septic shock due toCandidainfection
Bassetti, M., Vena, A., & Russo, A. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1518104 · Cited by 14
“In the ADRENAL study [22], among 3658 randomized patients, 1241 of them showedpositive cultures from different sample with Candida isolated in 38 (3%).”
BackgroundBourcier, S., Hindlet, P., Guidet, B., & Dechartres, A. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003746 · Cited by 14
High-Density Lipoproteins and Acute Kidney Injury
Smith, L. E. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.01.013 · Cited by 14
The cost-effectiveness of adjunctive corticosteroids for patients with septic shock
Thompson, K., Taylor, C. B., Venkatesh, B., Cohen, J., Hammond, N. E., Jan, S., Li, Q., Myburgh, J., Rajbhandari, D., Saxena, M. K., et al. (2020) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00386-1 · Cited by 14
Self-citationRapid Translation of COVID-19 Preprint Data into Critical Care Practice
Burrell, A. J. C., Neto, A. S., Trapani, T. V., Broadley, T., French, C., & Udy, A. A. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3661le · Cited by 11
The protective effect of rheumatic disease agents in COVID-19
Valenzuela-Almada, M. O., Putman, M., & Duarte‐García, A. (2021) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2021.101659 · Cited by 12
“Others have been equivocal, demonstrating no benefit in 90-daymortality for hydrocortisone [15] and only marginal improvement in outcomes with respect to ARDS [16,17].”
Decreased maximal cortisol secretion rate in patients with cirrhosis: Relation to disease severity
Lovato, C. M., Thévenot, T., Borot, S., Martino, V. D., Qualls, C., Urban, F. K., & Dorin, R. I. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100277 · Cited by 12
Billot, L., Cuthbertson, B. H., Gordon, A. C., Al-Beidh, F., Correa, M., Davis, J. S., Finfer, S. R., Glass, P., Goodman, F., Hammond, N. E., et al. (2021) · Critical Care and Resuscitation · doi:10.51893/2021.2.oa5 · Cited by 17
Self-citationWood, A. J. T., Rauniyar, R., Jacques, A., Palmer, R. N., Wibrow, B. A., & Anstey, M. (2022) · Anaesthesia and Intensive Care · doi:10.1177/0310057x221105297 · Cited by 12
Sepsis in a Panorama: What the Cardiovascular Physician Should Know
Gotur, D. B. (2018) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-14-2-89 · Cited by 15
A current appraisal of evidence for the approach to sepsis and septic shock
Varon, J., & Baron, R. M. (2019) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936119856517 · Cited by 12
Negative trials in critical care medicine and the hurdles
Legrand, M. M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30342-4 · Cited by 11
Haertel, F., Lehmann, T., Heller, T., Fritzenwanger, M., Pfeifer, R., Kretzschmar, D., Otto, S., Bogoviku, J., Westphal, J. G., Bruening, C., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154893 · Cited by 10
“Various strategies employed to manage the systemic inflammatory response through direct or indirect methods, such as steroids [12,21], plasma exchange [12,22], toll-like receptor antagonists [12,23], nitric oxide synthase inhibitors [12,24], or scavenger hemoglobin derivatives [12,25], have yielded conflicting or inco…”
BackgroundImmunomodulation in Pediatric Sepsis: A Narrative Review
Bottari, G., Taccone, F. S., Corrias, A., Irrera, M., Currao, P., Salvagno, M., Cecchetti, C., & Payen, D. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092983 · Cited by 15
“Conversely, another RCT involving 3800 adults with septic shock on mechanical ventilation found that continuous hydrocortisone infusion did not reduce 90-day mortality compared with a placebo (odds ratio 0.95; 95% confidence interval [CI] 0.82 to 1.10; p = 0.50) [51].”
InfluentialEvidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection
Chivukula, R. R., Maley, J. H., Dudzinski, D. M., Hibbert, K. A., & Hardin, C. C. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620969132 · Cited by 12
Labib, H. A., Hassan, A. I., Kamaly, A. M., Wahba, S. S., & Ammar, M. A. (2022) · Ain-Shams Journal of Anaesthesiology · doi:10.1186/s42077-022-00259-6 · Cited by 13
“The treatment with steroids has many several side effects like hyperglycemia and hypernatremia even though it might be lifesaving (Lee & Bainum, 2017; Venkatesh et al., 2018).”
BackgroundMethodInfluentialSteroids in the acutely ill: Evolving recommendations and practice
Pastores, S. M. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89gr.22002 · Cited by 10
Diagnosing sepsis in the ICU: Comparison of a gene expression signature to pre-existing biomarkers
Denny, K. J., Lea, R. A., Lindell-Innes, R., Haupt, L. M., Heffernan, A. J., Harvey, N. R., Hughes, O., Cao, V. T., Stuart, J., Paterson, D. L., et al. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154286 · Cited by 13
Vasoplegic Syndrome and Anaesthesia: A Narrative Review
Gökdemir, B. N., & Çekmen, N. (2023) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.4274/tjar.2023.221093 · Cited by 10
Survivorship outcomes for critically ill patients in Australia and New Zealand: A scoping review
Sutton, L., Bell, E. M., Every‐Palmer, S., Weatherall, M., & Skirrow, P. M. (2023) · Australian Critical Care · doi:10.1016/j.aucc.2023.07.008 · Cited by 12
Delaney, A. P., Tian, D. H., Higgins, A. M., Presneill, J., Peake, S., Venkatesh, B., Myburgh, J., Finfer, S. R., Thompson, K., Taylor, C. B., et al. (2023) · CHEST Critical Care · doi:10.1016/j.chstcc.2023.100024 · Cited by 11
Self-citationHellali, R., Dagdia, Z. C., Ktaish, A., Zeitouni, K., & Annane, D. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108017 · Cited by 11
“However, a comparative study on the e ff ect of hydrocortisone in patients with septic shock was performed in [12].”
BackgroundMethodThe Omics Complexity in Sepsis: The Limits of the Personalized Medicine Approach
Isac, S., Isac, T., Tănăsescu, M. D., Pavel, B., Andreescu, C. V., Badea, A.-G., Ojog, D., Teodorescu, G.-D., Laceanu, A., Trifan, C.-B., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14030225 · Cited by 12
“Both revealed that corticosteroids can shorten the duration of shock; however, the influence on survival differed between the two trials, with one of them reporting improved survival [68], while the other reported no difference [69].”
ResultChen, L., Yang, T., Wu, J., Cheng, G., Zhao, M., Zhou, Y., Wong, Y. K., Zhang, J., Guo, Q., Tang, H., et al. (2024) · Acta Materia Medica · doi:10.15212/amm-2024-0018 · Cited by 12
Steroids and Sepsis: the Debate Continues
Ramanan, M., Cohen, J., & Venkatesh, B. (2019) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000220 · Cited by 16
Self-citationCurrent opinion in management of septic shock due to Gram-negative bacteria
Tabah, A., Buetti, N., Barbier, F., & Timsit, J. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000767 · Cited by 11
Wentowski, C. C., Inglés, D. P., & Nielsen, N. D. (2021) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2021.10.001 · Cited by 15
Xiao, L., Niu, L., Xu, X., Zhao, Y., Yue, L., Liu, X., & Li, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.830030 · Cited by 10
Abrupt versus gradual cessation of steroids in patients with septic shock
Sobolewski, K. A., Brophy, A., Opsha, Y., Zaid, A., & Mistry, N. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.08.038 · Cited by 10
Acute Kidney Injury With Empirical Antibiotics for Sepsis
Tong, S. Y. C., Venkatesh, B., & McCreary, E. K. (2023) · JAMA · doi:10.1001/jama.2023.18591 · Cited by 12
Self-citationMitwally, H., Saad, M. O., Mahmoud, S., & Mohamed, A. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23501 · Cited by 9
“8,9 Cumulative evidence supports that hyperglycemia may be associated with a higher incidence of mortality in critically ill patients.”
Emerging concepts in the care of patients with cirrhosis and septic shock
Jiménez, J. V., García–Tsao, G., & Saffo, S. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i4.497 · Cited by 12
Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review
Zhou, H.-X., Yang, C.-F., Wang, H.-Y., Teng, Y., & He, H. (2023) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v12.i4.204 · Cited by 11
Ramsay, S. D., Nenke, M. A., Meyer, E. J., Torpy, D. J., & Young, R. L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1508848 · Cited by 9
He, Y., Chen, X., Zhong, J., Lin, C., Situ, J., Liu, B., Yan, Y., Gui, S., Mao, C., & Xing, S. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123744 · Cited by 11
Jackson, K. E., & Semler, M. W. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.05.003 · Cited by 11
Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions
Winkler, M. S., Osuchowski, M. F., Payen, D. M., Torres, A., Dickel, S., & Skirecki, T. (2022) · Critical Care · doi:10.1186/s13054-022-04185-9 · Cited by 10
“the APROCCHSS trial [16] among others, while some other large RCTs showed conflicting results including elevated mortality [17].”
ResultThe Metabolomics of Critical Illness
Pacheco-Navarro, A. E., & Rogers, A. J. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_622 · Cited by 13
Recent trends in septic shock management: a narrative review of current evidence and recommendations
Nofal, M. A., Shitawi, J., Altarawneh, H. B., Alrosan, S., Alqaisi, Y., Al-Harazneh, A.-M., Alamaren, A. M., & Abu‐Jeyyab, M. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002048 · Cited by 11
Hämodynamische Stabilisierung des septischen Patienten in der Notaufnahme
Schmoch, T., Bernhard, M. H., Siegler, B. H., Brenner, T., & Weigand, M. A. (2018) · Notfall + Rettungsmedizin · doi:10.1007/s10049-018-0515-7 · Cited by 9
Shepshelovich, D., Yahav, D., Tibau, A., & Amir, E. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.08.009 · Cited by 10
GILZ in sepsis: “Poor is the pupil who does not surpass his master”
Vandewalle, J., & Libert, C. (2020) · European Journal of Immunology · doi:10.1002/eji.202048582 · Cited by 11
McKenzie, K., Mayorga, M. E., Miller, K., Singh, N. K., Arnold, R. C., & Brufau, S. R. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.02.006 · Cited by 10
Foushee, J. A., Meredith, P., Fox, L. M., & Wilder, A. G. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa118 · Cited by 9
Habr, B., Saliba, Y., Hajal, J., Smayra, V., Riachy, M. A., & Farès, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118366 · Cited by 10
Donovan, K., Shah, A., Day, J., & McKechnie, S. (2021) · Anaesthesia · doi:10.1111/anae.15369 · Cited by 11
“[67] Multicentre RCT Australia, UK, NewZealand, Saudi Arabia, Denmark Sepsis, defined as strong clinical suspicion of infection, requiringmechanical ventilation,more than one 1 SIRS criterion and requiring vasopressors or inotropes for 4 h or longer n = 3800 Hydrocortisone 200 mg.”
BackgroundEffects of comprehensive nursing on negative emotion and prognosis of patients with sepsis.
Shen, G., He, Y., Ni, J., Jiang, L., Xia, Z., Liu, H., Pan, S., Wang, H., Hu, W., & Li, X. (2021) · PubMed · Cited by 12
Non-antibiotic therapies for sepsis: an update
Vincent, J., & Mongkolpun, W. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1581606 · Cited by 9
Adjunctive Corticosteroid Treatment in Septic Shock
Cohen, J., & Venkatesh, B. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002604 · Cited by 11
Self-citationEffect of intravenous vitamin C on adult septic patients: a systematic review and meta-analysis
Liang, H., Mu, Q., Sun, W., Liu, L., Qiu, S., Xu, Z., Cui, Y., Yan, Y., & Sun, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1211194 · Cited by 10
Cai, T., Chen, S., Wu, C., Lou, C., Wang, W., Lin, C., Jiang, H., & Xu, X. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-07028-y · Cited by 9
“Prolonged and high-dose steroid administration commonly leads to the development of steroid-induced avascular necrosis of the femoral head (SANFH), which can result in a significant disability rate [1].”
BackgroundASHCHERKIN, N., Abdalla, A., Gupta, S., Bhatt, S. K., Yee, C., & Cartin‐Ceba, R. (2024) · Acute and Critical Care · doi:10.4266/acc.2023.01046 · Cited by 8
Cao, L., Xiang, Y., Wu, Z., Chen, Q., Chen, F., Gui-ying, Y., & Li, H. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03196-7 · Cited by 11
Management of Sepsis in Hospitalized Patients
Palakshappa, J. A., & Taylor, S. P. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-02685 · Cited by 10
Shen, Y., Zhang, W. M., Lin, K., Zheng, P., Liu, X., Weng, J., & Ye, Y. (2026) · Critical Care · doi:10.1186/s13054-026-06059-w · Cited by 10
What Is the Role of Steroids for Septic Shock in 2021?
Nedel, W. L., Lisboa, T. C., & Salluh, J. I. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1733900 · Cited by 9
Vitamin C, Thiamine, and Steroids in the Sepsis Conquest: Replete to Defeat
Guirguis, E. H., Grace, Y., Maarsingh, H., Tran, T. C., & Tkachuk, E. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019851923 · Cited by 8
“The ADRENAL study published in 2018 was a randomized, double-blind, placebo-controlled, interventional phase 4 clinical trial, which included 3800 patients with septic shock on mechanical ventilation at nearly 60 different study sites.(13) The primary outcome was all-cause mortality at 90 days after randomization.”
BackgroundMethodResultInfluentialEffect of adjunctive corticosteroid on 28-day mortality in neutropenic patients with septic shock
Kang, J., Han, M., Hong, S., Lim, C., Koh, Y., & Huh, J. W. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03785-w · Cited by 8
Bonnin, S. S., Radosevich, J. J., Lee, Y. G., Feldman, J. P., & Barletta, J. F. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.12.001 · Cited by 8
Sepsis 2018: Bangkok, Thailand. 1-3 October 2018
(2018) · Intensive Care Medicine Experimental · doi:10.1186/s40635-018-0196-z · Cited by 9
Ram, G. K., Shekhar, S., Singh, R. B., Anand, R., De, R. R., & Kumar, N. (2022) · Anesthesia Essays and Researches · doi:10.4103/aer.aer_115_22 · Cited by 8
Feng, F., Yang, H., Yang, W., Li, M., & Chen, Y. (2023) · Open Medicine · doi:10.1515/med-2023-0637 · Cited by 8
Etomidate Is a First-Line Induction Agent in Critically Ill Patients
Lynde, G. C., & Jabaley, C. S. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003290 · Cited by 8
Fujii, T., Belletti, A., Carr, A. C., Furukawa, T. A., Luethi, N., Putzu, A., Sartini, C., Salanti, G., Tsujimoto, Y., Udy, A. A., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-033458 · Cited by 8
Self-citationPerioperative Management of Patients with Sepsis and Septic Shock, Part I
Bughrara, N. F., Cha, S., Safa, R., & Pustavoitau, A. (2020) · Anesthesiology Clinics · doi:10.1016/j.anclin.2019.10.013 · Cited by 12
Marshall, J. C. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00660-9 · Cited by 8
Shrestha, G. S., Sharma, S., Paneru, H. R., Shrestha, P. S., & Acharya, S. P. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24852 · Cited by 8
“20,21 We therefore assumed that a 7-day cut off would be sufficient for the comparison.”
Sepsis Endotypes Defined by Lymphocyte Thresholds and Inflammation Inform Precision Immunomodulation
Sun, Z., Li, L., Gao, W., Gao, H., Guo, L., & Peng, Z. (2026) · MedComm · doi:10.1002/mco2.70561 · Cited by 12
“The ADRENAL trial found no corticosteroid benefit in unselected patients [ 13 ], whereas APROCCHSS demonstrated mortality reduction with hydrocortisone plus flu-MedComm drocortisone [ 14 ].”
Sepsis: Heterogeneity, Immunopathology, and Advances in Therapeutic Strategies
Qu, J., Li, P., & Sun, Z. (2026) · The FASEB Journal · doi:10.1096/fj.202503685r · Cited by 7
“Clinical trials have yielded conflicting evidence, with some demonstrating benefit [134] and others showing no effect [135], contributing to ongoing uncertainty regarding their use.”
Low-dose corticosteroids in septic shock: Has the pendulum shifted?
Lemieux, S. M., & Levine, A. R. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz017 · Cited by 8
Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
Kröker, A., & Tirzīte, M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01885-8 · Cited by 8
Mahmoud, J., Bovy, M. A., Heming, N., & Annane, D. (2025) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2025.08.006 · Cited by 8
Wang, L., Li, B., Zuo, L., Pei, F., Nie, Y., Liu, Y.-J., Liu, Z., Wu, J., & Guan, X. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.02.005 · Cited by 7
Advancements in the pharmacological management of sepsis in the elderly
Psarrakis, C., & Giamarellos‐Bourboulis, E. J. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2213828 · Cited by 9
“0001) like in the APROCCHSS trial [81].”
Metadata
- Authors
- Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., Joyce, C., Li, Q., McArthur, C., Perner, A., Rhodes, A., Thompson, K., Webb, S., & Myburgh, J.
- Affiliations
- The University of Sydney (AU)
- From the George Institute for Global Health, University of New South Wales (B.V., S.F., D.R., L.B., M.C., P.G., M.H., Q.L., K.T., J.M.), St. George Clinical School, St. George Hospital (J.M.), Sydney Medical School, University of Sydney (B.V., S.F., J.M.), and Royal North Shore Hospital (S.F.), Sydney, the Princess Alexandra Hospital (B.V., C.J.) and Royal Brisbane and Women’s Hospital (J.C.), University of Queensland, and the Wesley Hospital (B.V., J.C.), Brisbane, Austin Hospital (R.B.), the...
- University of Copenhagen (DK)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-03
- Volume
- 378
- Issue
- 9
- Pages
- 797-808
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2784412824
- Cited by
- 1,037
- References
- 40
- Citations by year
- 2026: 111 · 2025: 122 · 2024: 90 · 2023: 106 · 2022: 110 · 2021: 121 · 2020: 149 · 2019: 135 · 2018: 91
- FWCI
- 96.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- Monash University Research Portal (Monash University) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Repository (Kingston University London) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- National Health and Medical Research Council (1004108, 1124926)
- Health Research Council of New Zealand (12/206)
- National Institute of Health Research, United Kingdom
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- septic shock, cortisol, mortality, mechanical ventilation, shock resolution, blood transfusion, intensive care unit, sepsis treatment, subgroup analysis, mechanical ventilation duration, vasopressor requirement, glycemic control
- MeSH terms
- Aged, Anti-Inflammatory Agents, Double-Blind Method, Female, Humans, Hydrocortisone, Infusions, Intravenous, Male, Middle Aged, Recurrence, Respiration, Artificial, Shock, Septic, Survival Rate, Fungemia, Bacteremia, Treatment Outcome, Chemotherapy, Adjuvant, Renal Replacement Therapy, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.